The clinical relevance of PTENP1 is underscored by its frequent downregulation in gastric cancer, squamous cell carcinoma, and other malignancies, where reduced PTENP1 expression correlates with decreased PTEN levels and worse clinical outcomes [98, 99, 100, 101, 102]. This evidence concerns the gene PTENP1 and gastric cancer.